Feier Horea, Grigorescu Andrei, Falnita Lucian, Rachita Oana, Gaspar Marian, Luca Constantin T
Department of Cardiology, University of Medicine and Pharmacy, 300391 Timisoara, Romania.
Divisions of Cardiovascular Surgery and Cardiology, Institute for Cardiovascular Diseases, 300391 Timisoara, Romania.
J Clin Med. 2021 May 11;10(10):2055. doi: 10.3390/jcm10102055.
The long-term performance of prostheses in the small aortic root is still unclear.
Patients who received a 21 mm or smaller aortic valve between 2000-2018 were retrospectively analyzed. Propensity matching was used in order to account for baseline differences in 19 mm vs. 21 mm valve subgroups.
Survival at 10 years was 55.87 ± 5.54% for 19 mm valves vs. 57.17 ± 2.82% for 21 mm ones in the original cohort ( = 0.37), and 58.69 ± 5.61% in 19 mm valve recipients vs. 53.60 ± 5.66% for 21 mm valve subgroups in the matched cohort ( = 0.55). Smaller valves exhibited significantly more patient-prothesis mismatch (PPM) than larger ones (87.30% vs. 57.94%, < 0.01). All-cause mortality was affected by PPM at 10 years (52.66 ± 3.28% vs. 64.38 ± 3.87%, = 0.04) in the unmatched population. This difference disappeared, however, after matching: survival at 10 years was 51.82 ± 5.26% in patients with PPM and 63.12 ± 6.43% in patients without PPM. ( = 0.14) Conclusions: There is no survival penalty in using 19 mm prostheses in the small aortic root in the current era. Although PPM is more prevalent in smaller sized valve recipients, this does not translate into reduced survival at 10 years of follow-up.
小型主动脉根部假体的长期性能仍不明确。
对2000年至2018年间接受21毫米或更小主动脉瓣的患者进行回顾性分析。采用倾向匹配法以考虑19毫米与21毫米瓣膜亚组的基线差异。
在原始队列中,19毫米瓣膜10年生存率为55.87±5.54%,21毫米瓣膜为57.17±2.82%(P = 0.37);在匹配队列中,19毫米瓣膜接受者的10年生存率为58.69±5.61%,21毫米瓣膜亚组为53.60±5.66%(P = 0.55)。较小瓣膜显示出比大瓣膜更多的患者-假体不匹配(PPM)(87.30%对57.94%,P<0.01)。在未匹配人群中,全因死亡率在10年时受PPM影响(52.66±3.28%对64.38±3.87%,P = 0.04)。然而,匹配后这种差异消失:有PPM的患者10年生存率为51.82±5.26%,无PPM的患者为63.12±6.43%(P = 0.14)。结论:在当前时代,在小型主动脉根部使用19毫米假体不会导致生存劣势。虽然PPM在较小尺寸瓣膜接受者中更普遍,但这在10年随访中并未转化为生存率降低。